Category Archives: Kidney

Dual live-donor transplant surgery conducted on 2-year-old – Times of India

This was originally published on this site

KOCHI: Grandmother donated her kidney and father donated his liver to save a two-year-old girl who weighed 7 kg, making her the smallest child in the world to have successfully undergone dual live-donor transplant.Doctors who performed the transplant at Aster Medcity said that the organ transplant manual states that a child should weigh at least 10kg for a transplant. Parvathy MS from Kodakara in Thrissur suffered from a rare congenital condition called primary hyperoxaluria type -1, in which the deficiency of a liver enzyme leads to abnormal spike in blood oxalate levels that permanently damage the kidneys.

“There is evidence of successful dual transplant being done on a child weighing 9 kg. But till date, no one has performed transplant on a child weighing 7 kg,” said Dr Mathew Jacob, consultant liver and abdominal multi-organ transplant surgeon, Aster Medcity.

However, the decision for transplant surgery was not immediate. “We wanted to wait till the child’s weight touched 10 kg. But when we realised that we would be risking her life if we waited, we discussed with the girl’s family and decided to go for transplant,” said Dr V Narayanan Unni, senior nephrologist, Aster Medcity.

Explaining their ordeal, Parvathy’s mother Saritha MS said that their daughter was first put on daily peritoneal dialysis when she was four months old. “The dialysis lasted for nearly 20 hours each day. After a year, she had to be put on ventilator and needed daily hemodialysis. But soon doctors said that transplant was the only option and they couldn’t wait longer,” said Saritha.

However, getting a donor, the baby’s size and age was not easy. Therefore, it was decided to take her grandmother’s kidney. But that had its own complications. While the adult kidney is nine and half to 11 cm, that of a child is 4 cm. Also almost half litre blood flows in the adult kidney in an hour, that’s the amount of blood flown in a child’s body. “The solution was to remove her damaged right kidney and place the new kidney. The blood volume in her kidney too had to be increased using highly specialised techniques,” added Dr Jacob.

“Post-transplant surgery in November 2016, the child was in the hospital for 51 days. She has recovered well and now weighs 10.4 kg,” said consultant paediatric intensivist Dr Rajappan Pillai.

Her grandmother, 53-yeear-old Sathi Raghavan added, “I told my son and daughter-in-law that I had to do this for my granddaughter. I am happy now as she able to move and breathe without much pain”.

Stay updated on the go with Times of India News App. Click here to download it for your device.

Language barriers may block access to kidney transplant waiting list – KFGO

This was originally published on this site

By Carolyn Crist

(Reuters Health) – Kidney transplant candidates who live in ZIP codes with more non-English speakers are less likely to make it onto the U.S. active waiting list, according to a recent study.

Those with linguistic barriers – especially in Hispanic and Asian households – also wait longer for a transplant evaluation or never complete one at all.

“The problem likely extends further than merely language. Cultural and educational barriers likely also play a role,” said senior study author Edmund Huang of the Kidney Transplant Program at Cedars-Sinai Medical Center in Los Angeles, California.

“Transplant centers and referring nephrologists should recognize that these populations may need additional attention in guiding them through the evaluation process,” he told Reuters Health.

The Organ Procurement and Transplantation Network currently has more than 98,000 candidates on the kidney transplant waiting list. Typically, a third of these patients are listed as inactive due to an incomplete transplant evaluation, and about a third of inactive candidates never become active. Figuring out why candidates remain inactive and how to move them to active status could reduce health disparities in underserved communities, the study authors write in the Clinical Journal of the American Society of Nephrology.

Huang and colleagues looked at nationwide organ transplant data, along with ZIP code data from the 2000 United States census, for more than 84,000 kidney transplant candidates from 2004-2012.

They defined a household as “linguistically isolated” if all members over age 14 spoke a language other than English and spoke English less than “very well.” The researchers then categorized neighborhoods where transplant candidates lived into one of five groups based on the percentage of households that were linguistically isolated: less than 1 percent, between 1 and 5 percent, between 5 and 10 percent, between 10 and 20 percent or more than 20 percent.

During the study, more than 70 percent of candidates moved to active status. These candidates were more often younger, male, more educated and more likely to have private health insurance. Inactive candidates generally lived in communities with lower education and more poverty. Although Hispanic, Asian and black candidates were all less likely to achieve active status, Hispanic and Asian candidates were more likely to live in areas with the highest levels of linguistic isolation.

Overall, 78 percent of candidates who lived in communities with less than 1 percent of linguistic isolation converted to active status. In communities that were more than 20 percent linguistically isolated, 69 percent converted to active status, researchers found.

“Despite our best efforts to make kidney transplantation accessible to all suitable patients with end-stage renal disease, there are barriers,” Huang said.

Although the nationwide kidney allocation policy changed in 2014 to reduce racial and ethnic disparities in kidney transplantation, the problem starts sooner than allocation, Huang added.

“When people need a transplant, they want to be sure that kidneys are allocated because of medical necessity and that they are not disadvantaged because of their social status,” said Alicia Fernandez of the University of California at San Francisco, who was not involved in the study.

“Kidney transplant is a scarce resource, and it is important that scarce medical resources be distributed fairly,” said Fernandez, who has studied language barriers in healthcare, particularly for Latinos with diabetes. “That has generally been understood to mean without unduly valuing social factors, such as wealth or race,” she said by email.

One limitation of the study is that although language barriers are likely tied to education and income barriers, the study authors can’t say for sure. Other systemic biases could prevent patients from completing evaluations or joining the waitlist, said Leah Karliner of the University of California at San Francisco, who wasn’t involved with the study but has studied language barriers to healthcare access and how professional interpreters may help.

“It is unclear how many of these patients had access to professional interpretation in their health care settings and for navigating the complex health care system to complete their evaluation,” she told Reuters Health by email. “An important starting place would be ensuring access to professional interpretation for all patients.”

SOURCE: Clinical Journal of the American Society of Nephrology, online February 9, 2017.

Language barriers may interfere with access to kidney transplantation –

This was originally published on this site
Getty Images/iStockphoto/ThinkStock
Getty Images/iStockphoto/ThinkStock
Language barriers may hinder U.S. kidney transplant candidates’ access to transplantation, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).

The findings suggest that patients who primarily speak a language other than English may face disparities that keep them from completing their kidney transplant evaluation and ultimately receiving a kidney transplant.

A team led by Ed Huang, MD (Cedars-Sinai Medical Center) and Efrain Talamantes, MD (University of California Davis School of Medicine) looked to see if language barriers, or linguistic isolation, might impact access to the active transplant waiting list.

The researchers merged Organ Procurement and Transplantation Network/United Network for Organ Sharing data with 5-digit zip code socioeconomic data from the 2000 United States census. They then determined the cumulative incidence of conversion to active waitlist status, death, and delisting before conversion among 84,783 temporarily inactive adult kidney candidates from 2004-2012.

A household was determined to be linguistically isolated if all members >14 years old speak a non-English language and also speak English less than “very well.”

Across all racial/ethnic groups, progressively higher degrees of linguistic isolation were linked with a lower likelihood of transitioning from inactive to active status on the kidney transplant waiting list and with incomplete transplant evaluations.

Candidates living in a community with >20% linguistically isolated households were 29% less likely to achieve active waitlist status than those residing in a community with <1% linguistically isolated households.

The associations of linguistic isolation and other socioeconomic factors appeared to be most influential among Hispanic candidates.

“Our data suggest that language barriers may limit an individual’s ability to receive a kidney transplant. We recommend that patients with limited English proficiency who are in need of a kidney transplant use patient advocates who are English-proficient during transplant clinic visits and always use interpreters to get all of their questions answered,” said Dr. Huang. “Further, transplant centers and healthcare providers should actively address potential communication barriers when recommending testing for transplant evaluation.”

Toddler gets kidney transplant from Illinois parents’ former classmate – WTVD-TV

This was originally published on this site

JOHNSBURG, Illinois —
A high school friendship was rekindled by a medical crisis and the reunion resulted in a young boy receiving a life-saving kidney transplant.
Two-and-a-half-year-old Miles Wagner is by all accounts a happy boy, despite a rare liver disease that has caused him to spend much of his young life in the hospital.

“The liver lacks a specific enzyme to detoxify an intermediary product of metabolism,” said Dr. Craig Langman with Lurie Children’s Hospital in Illinois.Miles underwent a liver transplant a year ago, but the metabolic abnormality had already caused kidney failure. Miles’ parents, Ashley and Ryan Wagner, took him to dialysis five days a week while waiting for a kidney donor.

That’s when Liz Wolodkiewicz, a high school classmate of Ryan’s, found out through Facebook that Miles needed help.

“I still remember the day that Miles got sick and how my heart just sank for them,” she said.

Wolodkiewicz got tested and found out she was a match for Miles after two other people did not qualify.

“It was the answer to many prayers. It was that light at the end of the tunnel we had been waiting for,” said Ashley Wagner, Miles’ mother.

On Monday, surgeons completed a successful procedure giving Miles one of Liz’s kidneys. It was a relief to his parents – especially Ryan Wagner, who is diagnosed with stage IV colon cancer. Ryan has gone through more than 70 rounds of chemotherapy and says Miles inspires him to stay positive.”He is just so happy with everything he does. It would almost make me feel guilty not to have the same kind of happiness even though I’m going through my own struggles,” Ryan Wagner said.

Liz said she had no second thoughts about the surgery and has only met Miles twice.

“He’s a little bit of a flirt. He gave me a kiss on the lips then he pushed my cheek and gave me a kiss on the cheek, too,” Wolodiewicz said.

Miles will need to take immuno-suppression medication for his donated organs the rest of his life, but his doctors say he should make a full recovery. He won’t need dialysis anymore and he’ll be able to be an active little boy.

Report a Typo

Indiana teen helps conduct train before kidney transplant – WISH-TV

This was originally published on this site

KOKOMO, Ind. (AP) — He doesn’t have his driver’s license yet, but Noah Mikel stopped traffic Jan. 25 when he helped conduct a train through Kokomo.

Mikel, a 16-year-old student from Northwood High School in Nappanee, can’t remember when he started loving trains, but he knows it was long before he started kidney dialysis seven years ago.

His kidney problems stretch back to when he was an infant; he had his first transplant at 3 years old, and on Feb. 1, he’ll have his second. But before the surgery, a few Kokomo train enthusiasts wanted to make sure he had the ride of his life.

Brad Ortman with Kokomo Grain heard about Mikel through a train engineer who had met Mikel at an apple festival. Mikel wasn’t as interested in the apples as he was the men manning the train tracks. Mikel shared his story with them, and it traveled back to Ortman, who knew he wanted to do something special for Mikel.

Kokomo Grain owns a few train cars to haul grain through the state, and Ortman used one to take Mikel on a ride through town. He organized the trip with two members of his crew, Engineer Danny Inskeep and Conductor Ethan Struwe.

Jim Thomas, a local train enthusiast and owner of the Central Indiana Yard Masters train club in Kokomo, met with Mikel before the ride. Thomas presented him with a custom, hand-painted model train. He also encouraged Mikel to visit his train shop, saying Mikel could run the model trains.

Mikel said he was grateful for the chance to ride on the train. He’d been on passenger trains before, but never cargo trains, and this was his first time being in the front with the engineer and the conductor.

The morning of the train ride, Mikel had a dialysis session at Riley Hospital for Children in Indianapolis, where he travels three times a week for treatment. His father, Lee Mikel, works every other day in order to take Noah to the hospital.

It’s a trip they’ve made for seven years, but after Feb. 1, Noah will be done with dialysis, hopefully for the rest of his life.

Lee found a kidney donor through the hospital, though he and his son haven’t met the donor yet; Lee said they plan to meet her soon. He’s been looking for a donor for a while. On his car, he has a picture of his son, his phone number and a plea for a donor matching Noah’s B+ blood type.

For Noah, the transplant will be one of the most freeing experiences of his life.

“I’ll get to start my life back again,” he said.

With dialysis, Noah can only drink about two water bottles worth of water each day, and he has to stay away from anything too salty. He’s looking forward to being able to drink just about anything he wants, though he’ll have to start drinking closer to 2 liters worth of fluids a day.

“I’m sick and tired of this dialysis,” he said. “It’s frustrating.”

And starting next semester, he’ll be able to attend school full-time. Currently, he attends on Tuesdays and Thursdays, and even after the transplant he’ll need to take it easy for several weeks to avoid infection, Lee said.

He’s looking forward to getting into a normal routine, he said. He hopes to travel to Florida over the summer with his uncle, and he hopes to get his driver’s license soon, though he said he’s a terrible driver.

Although he won’t have to travel to Riley much after the surgery, he said he plans to keep in contact with some of the other children he met during dialysis, as well as his nurses.

“It becomes like a family,” Lee said.

U of M research could help doctors predict kidney transplant rejection –

This was originally published on this site
A protein in urine may hold the key to helping doctors predict when a kidney will be rejected after a transplant. A new clinical trial led by researchers at the University of Manitoba could change how kidney transplant patients are monitored, and

The Robot That Performed My Kidney Transplant Declined to Be Interviewed – New York Times

This was originally published on this site

Times Insider delivers behind-the-scenes insights from The New York Times.

Ten years ago, I did not expect my brand new Twitter account to have much of an impact on my life. Yet it certainly has — affecting my career, my choice of where to live, my friendships, my adoption of pets, my intellectual lifestyle and even my emoji use. Now, Twitter has cost me a body organ. Yet my (voluntary!) loss is another Twitter user’s gain: I recently donated a kidney to a fellow journalist, Michelle Minkoff, who works at The Associated Press.

Interactive Feature | Times Insider

Michelle and I do similar jobs, writing both words and code for our separate news outlets. Our dual skills form an ill-defined newsroom role frequently called data journalism, which is a bland term for a diverse set of people, skills and interests.

Still, the small community of “news nerds” is strong and supportive. As active members, Michelle and I have many friends and peers in common, in addition to our jobs. Yet until the morning of the transplant itself, we had never met in person.

Ten years ago, Michelle was facing her first kidney transplant surgery after an autoimmune disease, IgA nephropathy, had weakened her kidneys to the point of failure. Michelle’s aunt, Karen Kwan, donated Michelle’s first transplanted kidney in 2006.

But Michelle’s autoimmune disease would eventually necessitate more transplants. A new donor from within her family was unlikely and not recommended by her doctors. Michelle had to hope for an “altruistic donor” to come along while she waited on the national transplant list.

Michelle is not a person who is resigned to waiting passively. Over the same 10 years, she had earned two degrees and started working at The A.P. She, too, had joined Twitter and found a home in the news nerd community.

Eighteen months ago, her donated kidney dropped into the warning area for kidney function. To Michelle, this meant it was time to crowdsource herself a new kidney. She rallied friends and fellow news nerds to help her set up a website and survey to seek volunteers. Family and friends — including many friends she and I have in common — amplified her posts on social media.

Michelle’s doctors were flabbergasted by her list of volunteers, as well as by her proactivity. As Michelle wrote in her blog chronicling the search, the response was “overwhelming — many who need a kidney struggle for years to find one person willing to be tested. These numbers are practically unheard-of.” From 48 people who joined the list, 14 were matches for basic blood-typing criteria, including me.

Subsequent tests confirmed I was her best match, which had felt inevitable to me from the start. But it still took months to get to the actual transplant. Finally, various medical and personal hurdles were cleared; we had a firm surgery date in early December. We both flew to Chicago for the last few tests.

Those days just before the surgery were simultaneously too quick and too slow. Too slow was the day before surgery, when we were restricted to a diet of only clear liquids. Of all the pre-surgery steps, that was the hardest for me: I could rationalize the uncomfortable tests I’d had earlier as abstract preventive health; it was more difficult to distract my stomach. Thankfully, clear liquids included the lighter shades of beer (I was donating a kidney, not a liver). I savored my beer dinner while others enjoyed the amazing delectables of the hotel sports bar.

Too fast was the morning of the surgery itself, which included a mandatory predawn shower followed by a subzero winter walk from my hotel to the hospital. I am not a morning person; my 4 a.m. self is a sleep-zombie. Once in the hospital, I struggled to keep up with the alarmingly cheery hospital staff as they prepped our concurrent surgeries. In the waiting room, I finally met Michelle and her family. I have little recollection of what was said, however. Even the prospect of surgery and its attendant risks isn’t enough to make me alert at that hour of the morning.

Our surgeries were robot-assisted — a newer surgical technique for organ transplants. It is the subject of much study, which now includes my own amateur sleuthing. I researched the robot, the company, their medical device offerings, the surgery technique (with and without robot), the surgical staff, their relevant published papers, their co-authors’ published papers, surgery videos, training videos, online donor forums and more.

Nothing I learned put me off robotic surgery — in fact, my enthusiasm grew as I learned more about what the robot’s advantages were, like working at angles that human hands can’t maintain for long. Also, I would be able to say I’d had robot-surgery, the fun of which overrode my concerns about risk ratios.

The downside of my surgical robot investigation was the parent company’s lack of interest in answering questions, even journalistic ones. When I asked, the company declined to make anyone available for discussion.

Part of my news nerd job at The New York Times is software development, which means I have a solid understanding of the kind of code one would write for a robot. So I had legitimate questions about the surgical robot’s software maintenance and upkeep. As a developer and a patient, I believed it was fair to ask whether the robot had the most recent software (or why not) and if surgical training had matched any upgrades.

Did I expect the robot to remove the wrong organ based on a bug in its software? No; mountains of lawyers would have seen to that concern. According to my surgeon, the hospital’s robots are maintained by the parent company as part of a yearly fee. As surgery approached and my voice mail messages and emails went unanswered, the implied judgment seemed to be that robot questions were too technical to be relevant — as if I had asked about the operating room’s lighting rather than voicing a legitimate medical concern.

I planned to ask brief questions about the robot the morning of the surgery: Any diagnostics? Did it make cool noises? Was there a green button that said “go!” that I could push? But as they wheeled me into the operating room, anesthesia took hold. I muttered “Robot!”; then there was blackness.

I woke up and it was done. My newly upholstered abdomen had five stitched-up incisions and my whole body seemed to be deer-in-headlights frozen in surprise. It was briefly shocking to see physical damage to my flesh yet have no sensory recollection of it happening. One of my first thoughts: Nobody needs to see this on Twitter. My nurse looked at me, amused, as if to ask, “What about Twitter?” (I must have mumbled it aloud.)

Tiff Fehr, less one kidney, back at work in The New York Times’s newsroom.

All told, I spent less than two days in the hospital. A few days after that, I was well enough to travel home to New York. During and after, I have spent many hours on Twitter and other social networks (but mostly Twitter) responding to kind inquiries after my and Michelle’s health.

I find it remarkable that Twitter’s social network helped make it all happen, just as I had begun to despair of Twitter’s value to me and to journalism. Like Michelle said, “It is a testament to the network and the community” that so many people followed our little story and influenced its happy ending.

This will definitely lead my list of anecdotes about the social network’s better qualities for the foreseeable future. (I also have anecdotes about its worst qualities, but that’s a different story.)

Medicare Pays For A Kidney Transplant, But Not The Drugs To Keep It Viable – NPR

This was originally published on this site
Cyclosporine is one of the drugs that organ transplant patients take so the body won’t reject the organ. Brendan Gates/Flickr hide caption

toggle caption

Brendan Gates/Flickr

The federal government will pay more than $100,000 to give someone a kidney transplant, but after three years, the government will often stop paying for the drugs needed to keep that transplanted kidney alive.

Constance Creasey is one of the thousands of people who find themselves caught up by this peculiar feature of the federal kidney program.

Creasey started kidney dialysis about 12 years ago after her kidneys failed. That meant going to a dialysis center three times a week, for three hours per session. (A typical patient undergoes 3 to 5 hours of dialysis per session).

“The first three years of dialysis was hard. I walked around with this dark cloud. I didn’t want to live, I really didn’t,” she says.

Being dependent on these blood-cleansing machines was physically and emotionally draining. But she stuck it out for 11 years. Medicare pays for dialysis, even for people under the age of 65. It also pays for kidney transplants for people with end-stage renal disease.

“Finally, a year and a half ago, transplant came. I was a little apprehensive but I said OK. And I call her Sleeping Beauty, that’s my kidney’s name.”

Creasey, a 60-year-old resident of Washington D.C., no longer needs to spend her days at a dialysis center. She has enough energy for a part-time job at a home furnishing store and time to enjoy life’s simple pleasures.

“I was able to do my favorite thing — go to the pool — and I was just loving it because it’s like I had no restrictions now,” she says.

Article continues after sponsorship

But there is still a dark cloud on Creasey’s horizon. Medicare’s kidney program currently pays for a large share of the expensive drugs she needs to take twice a day to prevent her body from rejecting the transplanted kidney. But under federal rules, that coverage will disappear three years after the date of her transplant.

“I have a year and a half to prepare, or save,” she says. “How am I going to do this?”

She’s already paying copays, premiums and past medical bills. She says she sleeps on the floor because she considers buying a bed a luxury she can’t afford.

She has no idea what kind of insurance she’ll be able to get after her Medicare coverage runs out. And she was shocked to discover how big the bills could be. One day she went into the pharmacy to pick up her drugs, and the Medicare payment hadn’t been applied.

The pharmacist told her she’d need to pay a $600 copay for the one-month supply. “And I’m like are you kidding me? Six hundred? What am I going to do? I can’t pay that!”

A social worker at MedStar Georgetown University Hospital in Washington D.C., where Creasey got her transplant, sorted that out. But it’s not a permanent solution.

The three-year cutoff for Medicare payments is a common problem, says Dr. Matthew Cooper, who runs the kidney transplant program at the hospital. That’s especially so since many people with serious kidney disease have low incomes in the first place.

“It’s probably about 30 percent of people who find themselves in a troublesome spot at this 36-month mark,” he says.

Some people end up trying to stretch out their drug supplies by not taking them as often as they need to, he says. “We see that a lot.”

But this isn’t like skipping a pain pill and bearing the consequences. People lose their transplanted kidneys through organ rejection if they don’t take their medicine religiously.

Rita Alloway, a clinical pharmacist at the University of Cincinnati, says she also encounters this false economy. “If we were telling them to take four pills days twice a day, they may start taking three pills twice a day without telling us, to extend their coverage that they had for the prescriptions they had,” she says.

If people tell her that they can’t afford it, she can help them get the medications for free, Alloway says. But sometimes people are too proud to admit their financial distress, she said.

And instead of spending $15,000 a year on these anti-rejection drugs, people go back onto dialysis, which costs $90,000 a year or more. And that’s taxpayer’s money, provided with no time limit.

Kevin Longino, CEO of the National Kidney Foundation, says it’s not just affecting the people who have transplants, but those who are on the long list waiting their turn for an organ to become available.

“The tragedy is you have so many people on the wait list already, and to have someone unnecessarily have rejection because they can’t afford the drugs and to have to go back into the system — it’s just a difficult thing to explain, why we’re allowing that to happen.”

Longino says insurance companies are making the problem even worse. Some have reclassified anti-rejection drugs as “specialty drugs,” and they now require patients to pay for a percentage of the cost, rather than a more traditional fixed copayment.

Longino encountered that himself after he had a kidney transplant about a dozen years ago. He says his costs went from $150 a month to $950 a month when his insurance company made that cost-sharing shift. Longino had to find a new job with better insurance.

He, Alloway and Cooper have been trying to persuade Congress to pass a bill to fix this problem. Rep. Michael Burgess, R-Texas, and Rep. Ron Kind, D-Wisc., have introduced bills more than once, but they have not moved through Congress. Burgess’ office says they plan to try again next year.

Lawmakers are concerned about the costs. Severe kidney disease already costs Medicare a staggering $30 billion a year, and there’s no official cost-benefit analysis showing whether covering transplant drugs for everybody would save money overall.

“The Medicare [savings] in maintaining this drug coverage is better than putting people on dialysis,” Cooper says. “To me this is a no brainer. I just cannot understand why we haven’t got to the point where we say Medicare coverage for life for immunosuppressive drugs because people will benefit and money will be saved.”

For Constance Creasey, this is not an abstract conversation.

“Those pills are my life right now,” she says. “I’m trying not to worry, but it’s hard.”

A young Medford boy is raising money for a kidney transplant – KOBI-TV NBC5 / KOTI-TV NBC2

This was originally published on this site

Medford, Ore. — A group called Team Alejandro is raising money for a young Medford boy who needs a kidney transplant.

Team Alejandro spent 12 hours Monday wrapping gifts for donations at the south Fred Meyer.

Tomorrow from 9am to 9pm they plan to do the very same thing.

“I’m kind of scared, but I’m also not because I’ve heard a lot of people that have had transplants… they’ve always said after the transplant you’ll feel like a brand new kid,” 10-year-old Alejandro said.

Alejandro was born with stage 4 kidney disease.

Now, 10 years later, he’s nearly a year away from getting a life-saving kidney transplant.

“Right now we’re doing the fundraising to get all the financial part out of the way so when his health gets worse we can focus on that,” Alejandro’s mom, Kyndra Boyd said.

Kyndra Boyd is a single mom of three.

She says their goal is to raise 50,000 dollars by February.

Wrapping gifts at the south Fred Meyer is just one of many fundraisers.

Boyd says she’s nervous about Alejandro’s transplant.

But his disease hasn’t stopped him from being his fun, outgoing self.

“Some of the people in the team Alejandro business are all like – they hate wrapping presents – and they’re doing this for me, so that’s what I think is cool about it,” Alejandro said.

Whether they enjoy it or not, Boyd is thankful to have so much help from the community.

“With everybody’s support it’s been crazy. It’s overwhelming feeling. I can’t thank anybody enough,” Boyd said.

Donations can be accepted online at

You can also follow Alejandro’s journey on the Team Alejandro Facebook page:

NBC5 News Multimedia Journalist Elizabeth Ruiz was raised in Northern Colorado. She graduated from Colorado State University with a degree in Journalism and Media Communication. She also minored in Spanish and studied in Spain. While at Colorado State, she was an anchor and reporter for CTV Channel 11.
Elizabeth loves Zumba dancing, singing and spending time with her family.

Leave a Comment:

Note: By commenting below you agree to abide by the commenting guidelines. View the Comment Board Guidelines »

CareDx and Leading Transplant Clinicians to Present AlloSure® DART Data During Kidney Week at the American … – GlobeNewswire (press release)

This was originally published on this site

CareDx and Leading Transplant Clinicians to Present AlloSure® DART Data During Kidney Week at the American …
GlobeNewswire (press release)
BRISBANE, Calif., Nov. 16, 2016 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant …

and more »

Inspiration + Education : . . . . for parents of children who are going through transplant

%d bloggers like this: